These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8714809)
21. Neurologic complications of phenylpropanolamine use. Mueller SM Neurology; 1983 May; 33(5):650-2. PubMed ID: 6682504 [TBL] [Abstract][Full Text] [Related]
22. Phenylpropanolamine-induced psychosis. Potential predisposing factors. Marshall RD; Douglas CJ Gen Hosp Psychiatry; 1994 Sep; 16(5):358-60. PubMed ID: 7995508 [TBL] [Abstract][Full Text] [Related]
23. Phenylpropanolamine and mental disturbances. Norvenius G; Widerlöv E; Lönnerholm G Lancet; 1979 Dec 22-29; 2(8156-8157):1367-8. PubMed ID: 92706 [No Abstract] [Full Text] [Related]
24. Levodopa and amantadine in the treatment of Parkinsonism. Critchley E Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037 [No Abstract] [Full Text] [Related]
25. Homicidal psychosis during the combined use of cocaine and an over-the-counter cold preparation. Strauss A J Clin Psychiatry; 1989 Apr; 50(4):147. PubMed ID: 2925605 [No Abstract] [Full Text] [Related]
26. Acute toxic psychosis from suicidal overdosage of amantadine. Fahn S; Craddock G; Kumin G Arch Neurol; 1971 Jul; 25(1):45-8. PubMed ID: 5146411 [No Abstract] [Full Text] [Related]
28. Amantadine in Chinese 'Cold and Flu' tablets: the cause of psychosis in a healthy man. Turbayne AKB; Xu TT; Swaminathan A Intern Med J; 2018 May; 48(5):601-602. PubMed ID: 29722187 [No Abstract] [Full Text] [Related]
30. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB; Shealy CN; Mercier DA Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
35. Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. Handelsman L; Limpitlaw L; Williams D; Schmeidler J; Paris P; Stimmel B Drug Alcohol Depend; 1995 Oct; 39(3):173-80. PubMed ID: 8556965 [TBL] [Abstract][Full Text] [Related]
36. Psychiatric reactions produced by respiratory drugs. Hall RC; Beresford TP; Stickney SK; Nasdahl CS; Coleman JH Psychosomatics; 1985 Jul; 26(7):605-8, 615-6. PubMed ID: 2410944 [No Abstract] [Full Text] [Related]
37. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease]. Hacohen H; Gurtner B Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377 [No Abstract] [Full Text] [Related]
38. Phenylpropanolamine for weight reduction. Med Lett Drugs Ther; 1984 Jun; 26(663):55-6. PubMed ID: 6374401 [No Abstract] [Full Text] [Related]
39. Amantadine in the treatment of Parkinson's disease. Schwab RS; England AC; Poskanzer DC; Young RR JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715 [No Abstract] [Full Text] [Related]
40. Renaissance of amantadine in the treatment of Parkinson's disease. Blanchet PJ; Metman LV; Chase TN Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]